News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major economic data releases were reported in the past hour.
  • Global equity and bond markets showed no significant moves in the last hour.
  • No central bank statements or policy changes were announced in the past hour.
  • No new geopolitical incidents or conflicts were reported in the past hour.
  • No material corporate earnings, M&A, or major corporate announcements emerged this hour.

Latest Articles

North Korea Warns U.S. Forces Japan Expansion Raises Prospect of Peninsula Clash

North Korea Warns U.S. Forces Japan Expansion Raises Prospect of Peninsula Clash

North Korean state media criticized the growth of the U.S. Forces Japan headquarters and allied military cooperation, saying the expansion makes a clash on the Korean Peninsula a matter of timing. The commentary followed U.S. Forces Japan commander Lt. Gen. Stephen Jost’s confirmation of a 215-personnel increase to strengthen command functions and …

Tech Earnings Lift Futures as Amazon Climbs and Apple Tumbles

Tech Earnings Lift Futures as Amazon Climbs and Apple Tumbles

U.S. stock index futures moved higher on Thursday evening after a strong session on Wall Street, driven by upbeat earnings from Amazon and Microsoft that supported technology names and chipmakers. Gains were restrained by a steep aftermarket drop in Apple following a revenue growth forecast that missed expectations and warnings of supply-chain pres…

Cuba Details Program to Open State-Dominated Sectors as U.S. Pressure Mounts

Cuba Details Program to Open State-Dominated Sectors as U.S. Pressure Mounts

Cuba unveiled expanded plans to permit greater private participation in targeted state-controlled industries as U.S. sanctions and an oil blockade intensify pressure on the economy. Lawmakers discussed measures to ease land-use rules, let businesses import fuel and medicine, and allow private tourist operators. Officials emphasized the changes will…

Churchill Capital Corp XIII Prices $360 Million IPO on Nasdaq Global Market

Churchill Capital Corp XIII Prices $360 Million IPO on Nasdaq Global Market

Churchill Capital Corp XIII has priced an upsized initial public offering of 36,000,000 units at $10.00 per unit, generating $360 million. The units are trading on the Nasdaq Global Market as XIIIU and include a Class A ordinary share and one-tenth of a redeemable warrant. The offering is expected to close on August 3, 2026, subject to customary cl…

Trump Says Board of Peace Secures Deal for Hamas Disarmament in Gaza

Trump Says Board of Peace Secures Deal for Hamas Disarmament in Gaza

U.S. President Donald Trump announced that his so-called 'Board of Peace' has reached an agreement calling for the complete disarmament of Hamas and other armed groups in Gaza. The plan, described as a milestone in the implementation of the Trump 20-Point Plan, envisions phased disarmament, Israeli troop withdrawals, and an International Stabilizat…

Telix H1 2026 Results: Investor Webcast Notification

Telix H1 2026 Results: Investor Webcast Notification

Telix Pharmaceuticals Limited will release its financial results for the half-year ended June 30, 2026, on August 20, 2026, accompanied by an investor webcast and conference call. The company is a commercial-stage global radiopharmaceutical firm focused on targeted theranostics for cancer treatment and diagnosis, with an established prostate cancer…

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Replimune Group, Inc. announced a favorable outcome from the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee regarding the Biologics License Application resubmission for RP1, an oncolytic immunotherapy, used in combination with nivolumab to treat advanced melanoma patients who progressed after prior anti-PD-1 therapy. The committee vo…

First Solar Pops After Q2 Results; Margins Reach Multi-Year Highs

First Solar Pops After Q2 Results; Margins Reach Multi-Year Highs

First Solar's shares climbed in after-hours trading after the company reported a major second-quarter earnings beat, with adjusted EPS of $3.92 versus a $3.01 consensus. Revenue matched estimates at $1.06 billion, while gross margin expanded to about 57%, aided by tariff-related provisions, advanced manufacturing tax credits and lower logistics cos…

MasTec Shares Plummet After Q2 Results Fail to Satisfy Elevated Expectations

MasTec Shares Plummet After Q2 Results Fail to Satisfy Elevated Expectations

MasTec Inc reported second-quarter 2026 results that were broadly in line with analyst forecasts but fell short of the lofty expectations baked into its stock. While revenue, adjusted EPS and backlog showed solid year-over-year gains, the company’s guidance raise and other developments did not quell profit-taking following a sizable run-up in the s…

DexCom Shares Jump After Q2 Beat, Margins Improve Sharply

DexCom Shares Jump After Q2 Beat, Margins Improve Sharply

DexCom's shares jumped 10.0% in after-hours trading after the continuous glucose monitoring company reported second-quarter 2026 results that topped analyst expectations across key metrics, including adjusted EPS of $0.70 and revenue of $1.31 billion. Gross margins and operating profit expanded materially, management left full-year revenue guidance…